Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001829126-25-001317
Filing Date
2025-02-28
Accepted
2025-02-28 11:32:21
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 ownership.html 3  
1 FORM 3 ownership.xml 3 2522
  Complete submission text file 0001829126-25-001317.txt   4145
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LEVEL 10, TOWER 11, AVENUE 5, NO. 8 JALAN KERINCHI, BANGSAR SOUTH WILAYAHPERSEKUTUANKUALA LUMPUR N8 59200
Business Address
Doris Wong Sing Ee (Reporting) CIK: 0001892421 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25685143